PELLICANO, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 627
EU - Europa 363
AS - Asia 119
AF - Africa 6
OC - Oceania 4
SA - Sud America 1
Totale 1.120
Nazione #
US - Stati Uniti d'America 621
IT - Italia 208
SE - Svezia 81
SG - Singapore 60
IN - India 41
DE - Germania 20
CN - Cina 15
BG - Bulgaria 11
FI - Finlandia 8
FR - Francia 7
UA - Ucraina 6
CA - Canada 5
GB - Regno Unito 5
TG - Togo 5
AU - Australia 4
LU - Lussemburgo 3
PL - Polonia 3
RO - Romania 3
GR - Grecia 2
IE - Irlanda 2
AR - Argentina 1
CZ - Repubblica Ceca 1
IL - Israele 1
KR - Corea 1
LV - Lettonia 1
MX - Messico 1
NL - Olanda 1
PT - Portogallo 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 1.120
Città #
Rome 87
Ashburn 84
Chandler 83
Fairfield 69
New York 30
Singapore 27
Cambridge 26
Wilmington 26
Princeton 23
Seattle 23
Woodbridge 23
Houston 22
Millbury 19
San Paolo di Civitate 19
Beijing 14
Frankfurt am Main 13
Lawrence 13
San Diego 12
Sofia 11
Boardman 10
Rocca d'Evandro 10
Andover 9
Milan 9
Ann Arbor 8
Boston 8
Lappeenranta 7
Lomé 5
Padova 5
Toronto 5
Ciampino 4
Formia 4
Hyderabad 4
Pune 4
Sydney 4
Los Angeles 3
Alessandria 2
Athens 2
Avellino 2
Bologna 2
Conegliano 2
Dearborn 2
Dublin 2
Fregene 2
Genoa 2
Krakow 2
London 2
Norwalk 2
Portici 2
Sulmona 2
Turin 2
Aci Catena 1
Agropoli 1
Azor 1
Bagheria 1
Bühl 1
Carloforte 1
Des Moines 1
Federal 1
Fremont 1
Frosinone 1
Gelsenkirchen 1
Groningen 1
Guwahati 1
Helsinki 1
High Peak 1
Iasi 1
Islington 1
Leverano 1
Lisbon 1
Mannheim 1
Mexico City 1
Muizenberg 1
Mykolayiv 1
Naples 1
Napoli 1
Paris 1
Plano 1
Provo 1
Quartucciu 1
Rovigo 1
San Jose 1
San Mateo 1
Scafati 1
Seoul 1
Solan 1
Spinetoli 1
Szczecin 1
Taipei 1
Trumbull 1
Totale 792
Nome #
CD21low B cells in systemic sclerosis: a possible marker of vascular complications 72
Recurrent angioedema: occurrence, features, and concomitant diseases in an Italian single-center study 66
Microbiome, Autoimmune Diseases and HIV Infection: Friends or Foes? 64
Early benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis 60
The predictive role of lung ultrasound in progression of scleroderma interstitial lung disease 58
Comparisons of skin microvascular changes in patients with primary aldosteronism and essential hypertension 53
CD21 low B cells are predictive markers of new digital ulcers in systemic sclerosis 46
In systemic sclerosis patients the anxiety disorder and Raynaud’s phenomenon are increased during lock down period for COVID-19 pandemic 42
Contrast-Induced Acute Kidney Injury and Endothelial Dysfunction: The Role of Vascular and Biochemical Parameters 40
Renal parenchymal thickness is both related to vascular endothelial growth factor and intrarenal stiffness in systemic sclerosis 39
Symptoms related to gastrointestinal tract involvement and low muscularity in systemic sclerosis 37
Skin perfusion of hands is associated with parasympathetic activity in systemic sclerosis 34
Parasympathetic activity and total fibrotic kidney in autosomal-dominant polycystic kidney disease patients: a pilot study 33
Increased complement activation in systemic sclerosis patients with skin and lung fibrosis 32
Estimated glomerular filtration rate and renal resistive index as possible predictive markers of mortality in systemic sclerosis 31
Color doppler ultrasonography of digital arteries and digital ulcers development in systemic sclerosis 30
Assessment of renal microcirculation in biopsy-proven tubulointerstitial nephritis in patients with and without glomerular disease: the role of resistive index 30
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis 29
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 27
Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis 27
In systemic sclerosis {TAPSE}/{sPAP} ratio can be used in addition to the {DETECT} algorithm for pulmonary arterial hypertension diagnosis 26
IL33 and sST2 serum level in systemic sclerosis microvascular involvement 24
Reciprocal effects of scleroderma and temporomandibular dysfunction between patient cohorts 22
The effect of SARS-CoV-2 vaccination on B-cell phenotype in systemic sclerosis patients 20
Phase angle, nutritional status, and mortality in systemic sclerosis. An exploratory pilot study 20
Maresin1 is a predictive marker of new digital ulcers in systemic sclerosis patients 20
In systemic sclerosis TAPSE/sPAP ratio is correlated with ventilatory efficiency and exercise capacity assessed by CPET 20
Assessment of kidney involvement in systemic sclerosis: from scleroderma renal crisis to subclinical renal vasculopathy 20
Might IgA be a biomarker of disease activity in Takayasu arteritis 19
Kidney Biopsy and Immuno-Rheumatological Diseases: A Retrospective and Observational Study 15
In acromegalic patients the serum levels of interleukin-33 and Resolvin D1 influence skin perfusion of hands: A pilot study 14
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort 14
IN SYSTEMIC SCLEROSIS (SSC) PATIENTS, PERIPHERAL BLOOD CD21LOW B CELLS INFLUENCE JOINTS INVOLVEMENT 14
Role of kinurenic acid in the systemic sclerosis renal involvement 13
Parasympathetic activity and total fibrotic kidney in autosomal-dominant polycystic kidney disease patients: a pilot study 12
Nephroangiosclerosis not related to hypertension: a matter to resolve in the era of precision medicine 12
Resistant hypertension and related outcomes in a cohort of patients with cardiorenal multimorbidity hospitalized in an internal medicine ward 12
Tubular changes in autosomal dominant polycystic kidney disease patients. observational study 12
Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement 11
Role of IL33 in chronic inflammation and microvascular damage as a reflection of organ damage on a cohort of patients with acromegaly 11
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 10
Serum immunoglobulin G (IgG) subclasses in a cohort of systemic sclerosis patients 10
Changes in renal microcirculation in patients with nephrotic and nephritic syndrome. the role of resistive index 8
GLIM-diagnosed malnutrition predicts mortality and risk of hospitalization in systemic sclerosis. A retrospective study 8
CHEST WALL MUSCLE AREA AND EXERCISE CAPACITY IN SYSTEMIC SCLEROSIS 8
Type 2 cytokines and scleroderma interstitial lung disease 7
Kidney dysfunction is associated with adverse outcomes in internal medicine COVID-19 hospitalized patients 6
SERUM LIPOPOLYSACCHARIDE-BINDING PROTEIN (LBP) IS ASSOCIATED WITH DIGITAL ULCERS (DUS) IN SYSTEMIC SCLEROSIS (SSC) PATIENTS 5
Serum-soluble ST2 and systemic sclerosis arthropathy 3
ILOPROST INFUSION REDUCES NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) SERUM LEVELS IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 3
In Systemic Sclerosis Patients, Peripheral Blood CD21low B Cells and Serum IL-4 and IL-21 Influence Joint Involvement 2
Serum kynurenic acid is lower in systemic sclerosis patients with microvascular damage of hands 2
COVID-19 Infection in Autosomal Dominant Polycystic Kidney Disease and Chronic Kidney Disease Patients: Progression of Kidney Disease 2
Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio and Cardiorenal Syndrome Type 2 in the Systemic Sclerosis EUSTAR Cohort 2
Thymic stromal lymphopoietin and digital microvascular damage in systemic sclerosis patients: A pilot study 1
Totale 1.258
Categoria #
all - tutte 5.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.722


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020137 3 1 0 3 18 7 29 14 21 14 17 10
2020/202170 4 11 10 2 0 16 5 1 13 0 4 4
2021/2022215 31 6 9 5 19 8 3 11 30 14 40 39
2022/2023372 51 56 11 35 41 29 30 29 34 7 31 18
2023/2024447 9 67 25 41 31 87 34 17 6 27 46 57
2024/202514 14 0 0 0 0 0 0 0 0 0 0 0
Totale 1.258